Abstract 9032: Restoration of Normal Cardiomyocyte Basal and β-Adrenergic Receptor (AR) Subtype Modulation in Diabetic Cardiomyopathy by Chronic Selective Beta3-AR Antagonist in a Mouse Model of Type 2 Diabetes
Jing Cao,Xiaoqiang Sun,Heng Cheng,Yixi Liu,Zhe Chen,David Zhao,Donald McClain,Dalane W Kitzman,Che Ping Cheng,Jing CaoXiaoqiang SunHeng ChengYixi LiuZhe ChenDavid ZhaoDonald McClainDalane W KitzmanChe Ping ChengWake Forest Sch of Medicine,Winston-Salem,NC
DOI: https://doi.org/10.1161/circ.144.suppl_1.9032
IF: 37.8
2021-11-10
Circulation
Abstract:Background: We have shown that L-748,337 (L-7), a selective β 3 -adrenergic receptor (AR) antagonist reversed LV dysfunction and β-AR desensitization in diabetes (DM) caused diabetic cardiomyopathy (DCM). The mechanism is unclear. Recent evidence suggests that normal myocardial performance depends on the balance in myocyte β 3 -, β 1 -, and β 2 -AR. Pivotal restructuring of β-AR system resulting in the decline of β-AR reserve plays a crucial role in DCM. We assessed the hypothesis that chronic L-7 would prevent DCM-induced abnormalities of β-AR subtype-stimulated regulation on intrinsic LV myocyte function and [Ca 2+ ] i regulation, thus restoring cardiac function. Methods: Studies were conducted in 3 groups of female mice: Type 2 DM (T2) (n=9), induced with high-fat diet (HFD) intake for 14 weeks (W), but after fed HFD for 4 W receiving streptozotocin (STZ, 40 mg/kg/day, i.p. for 5 days); T2/L-7 (n=7), T2 mice at 10 W received L-7 (10 -7 M/kg/day, mini-pump) for 4 W; and Controls (C)(n=9). We compared LV myocyte contractile and [Ca 2+ ] iT responses to β-AR subtype stimulation by random exposure of myocytes to Isoproterenol (ISO,10 -8 M) or a selective β 1 -, β 2 -, or β 3 -agonist, Norepinephrine (NE, 10 -7 M), Zinterol (ZIN, 10 -5 M) and BRL-37,344 (BRL, 10 -8 M), respectively, during drug perfusion. Results: T2 and T2/L-7 mice had mean blood glucose levels of 388 mg/dl and 369 mg/dl, respectively. Versus C, only in T2, basal LV myocyte contractility (dL/dt max , 76 vs 133 μm/s), relaxation and [Ca 2+ ] iT (0.16 vs 0.21) were significantly decreased. ISO-stimulated dL/dt max (40% vs 58%) was attenuated accompanied by a diminished NE-mediated increase in dL/dt max (28% vs 44%), but enhanced BRL-induced decreases in dL/dt max (29% vs 12%).The response of dL/dt max (24% vs 15%) to ZIN was increased. Importantly, in T2/L-7 myocytes, the basal dL/dt max (128 μm/s) and [Ca 2+ ] iT (0.21) remained close to control values with preserved β-stimulated positive modulation on cell contraction. The increases in dL/dt max in response to ISO (57%), NE (40%) or ZIN (15%) were similar to that in control myocytes, respectively. Conclusions: Chronic β 3 -AR antagonist reverses β-AR signaling defects, resensitizing the β-AR subtype system modulation on LV myocytes function, thus playing a salutary role in DCM.
cardiac & cardiovascular systems,peripheral vascular disease